EYE 3.33% 14.5¢ nova eye medical limited

On Track to Profitability, Price Target Increased (MST), page-17

  1. 213 Posts.
    lightbulb Created with Sketch. 20
    Open question: why do we keep talking of a CR, why not a debt facility?

    I agree 3.3m balance is too much of a risk, but seems like if we go into debt for a couple of years (going say 5m into debt) would carry us to profitability, to which now it is a matter of paying back that debt and seems like by FY27 we would be making much more than that a year.

    In all honesty, March's cap raise was needed and was good to accelerate on the sales department, but the discount they gave was outrageous and here we are seeing the SP struggling because many are not going to fall into that trap again.
    I don't care about the share price action (have an order there waiting to be filled) but if they raise in the next few months, and happens to be at a heavier discount than 10%, I'll be really disappointed.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
14.5¢
Change
-0.005(3.33%)
Mkt cap ! $33.21M
Open High Low Value Volume
14.8¢ 15.0¢ 14.5¢ $34.06K 232.5K

Buyers (Bids)

No. Vol. Price($)
4 329492 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 244742 3
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.